Insider Trading in U.S. Stocks | Cencora disclosed three insider trading transactions on March 13

On March 13, 2026, Cencora (COR) disclosed three insider trading transactions. Executive Campbell Elizabeth S sold 5,842 shares on March 11, 2026.

【Recent Insider Transactions】

【Company Information】

Cencora, Inc. is one of the world’s largest pharmaceutical purchasing and distribution service companies, helping healthcare providers as well as pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care opportunities. The company offers innovative programs and services aimed at increasing the efficiency and effectiveness of the drug supply chain in human and animal health. Specifically, the company provides comprehensive brands, specialty brands, and non-patented drugs, over-the-counter medical products, home healthcare supplies and equipment, and related services to various healthcare providers in the U.S. and select global markets, including acute care hospitals and health systems, independent and chain retail pharmacies, mail-order pharmacies, clinics, long-term care and alternative site pharmacies, physician practices, medical and dialysis clinics, veterinarians, and other clients. Additionally, the company offers a range of related services for healthcare providers and pharmaceutical manufacturers, including data analytics, outcomes research, reimbursement and drug consulting services, niche premium logistics, inventory management, pharmacy automation, pharmacy management, and packaging solutions.